BACKGROUND: Converging evidence suggests that immune-mediated dysfunction plays an important role in the pathogenesis of frontotemporal dementia (FTD). Although genetic studies have shown that immune-associated loci are associated with increased FTD risk, a systematic investigation of genetic overlap between immune-mediated diseases and the spectrum of FTD-related disorders has not been performed. CONCLUSIONS: We show immune-mediated genetic enrichment specifically in FTD, particularly within the HLA region. Our genetic results suggest that for a subset of patients, immune dysfunction may contribute to FTD risk. These findings have potential implications for clinical trials targeting immune dysfunction in patients with FTD.

Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies / Broce, Iris; Karch, Celeste M; Wen, Natalie; Fan, Chun C; Wang, Yunpeng; Tan, Chin Hong; Kouri, Naomi; Ross, Owen A; Höglinger, Günter U; Muller, Ulrich; Hardy, John; Momeni, Parastoo; Hess, Christopher P; Dillon, William P; Miller, Zachary A; Bonham, Luke W; Rabinovici, Gil D; Rosen, Howard J; Schellenberg, Gerard D; Franke, Andre; Karlsen, Tom H; Veldink, Jan H; Ferrari, Raffaele; Hernandez, DG; Nalls, MA; Rohrer, JD; Ramasamy, A; Kwok, JBJ; Dobson-Stone, C; Brooks, WS; Schofield, PR; Halliday, GM; Hodges, JR; Piguet, O; Bartley, L; Thompson, E; Haan, E; Hernández, I; Ruiz, A; Boada, M; Borroni, B; Padovani, A; Cruchaga, C; Cairns, NJ; Benussi, L; Binetti, G; Ghidoni, R; Forloni, G; Galimberti, D; Fenoglio C; Serpente, M; Scarpini, E; Clarimón, J; Lleó, A; Blesa, R; Waldö, ML; Nilsson, K; Nilsson, C; Mackenzie, IRA; Hsuing, GYR; Mann, DMA; Grafman, J; Morris, CM; Attems, J; Griffiths, TD; McKeith, IG; Thomas, AJ; Pietrini, P; Huey, ED; Wasserman, EM; Baborie, A; Jaros, E; Tierney, MC; Pastor, P; Razquin, C; Ortega-Cubero, S; Alonso, E; Perneczky, E; Diehl-Schmid, J; Alexopoulos, P; Kurz, A; Rainero, I; Rubino, E; Pinessi, L; Rogaeva, E; St George-Hyslop, P; Rossi, G; Tagliavini, F; Giaccone, G; Rowe, JB; Schlachetzki, JCM; Uphill, J; Collinge, J; Mead, S; Danek, A; Van Deerlin, VM; Grossmann, M; Trojanowski, Q; van der Zee, J; Deschamps, W; Van Langenhove, T; Cruts, M; Van Broeckhoven, C; Cappa, SF; Le Ber, I; Hannequin, D; Golfier, V; Vercelletto, M; Brice, A; Nacmias, B; Sorbi, S; Bagnoli, S; Piaceri, I; Nielsen, JE; Hjermind, LE; Riemenschneider, M; Mayhaus, M; Ibach, B; Gasparoni, G; Pichler, S; Gu, W; Rossor, MN; Fox, NC; Warren, JD; Spillantini, MG; Morris, HR; Rizzu, P; Heutnik, P; Snowden, J; Rollinson, S; Richardson, A; Gerhard, A; Bruni, AC; Maletta, R; Frangipane, F; Cupidi, C; Bernardi, L; Anfossi, M; Gallo, M; Conidi, ME; Smirne, N; Rademakers, R; Baker, M; Dickson, DW; Graff-Radford, NR; Peterson, RC; Knopman, D; Josephs, KA; Boeve, BF; Parisi, JE; Seeley, WW; Miller, BL; Karydas, AM; Rosen, H; van Swieten, JC; Dopper, EGP; Seelaar, H; Pijnenburg, YAL; Scheltens, P; Logroscino, G; Capozzo, R; Novelli, V; Puca ,AA; Franceschi, M; Postiglione, A; Milan, G; Sorrentino, P; Kristiansen, M; Chiang, HH; Graff, C; Pasquier, F; Rollin, A; Deramecourt, V; Lebert, F; Kapogiannis, D; Ferucci, L; Pickering-Brown, S; Singleton, AB; Hardy, J; Momeni, P; Yokoyama, Jennifer S; Miller, Bruce L; Andreassen, Ole A; Dale, Anders M; Desikan, Rahul S; Sugrue, Leo P. - In: PLOS MEDICINE. - ISSN 1549-1277. - ELETTRONICO. - 15:(2018), pp. e1002487-0. [10.1371/journal.pmed.1002487]

Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies

Nacmias, B;Sorbi, S;Bagnoli, S;Piaceri, I;
2018

Abstract

BACKGROUND: Converging evidence suggests that immune-mediated dysfunction plays an important role in the pathogenesis of frontotemporal dementia (FTD). Although genetic studies have shown that immune-associated loci are associated with increased FTD risk, a systematic investigation of genetic overlap between immune-mediated diseases and the spectrum of FTD-related disorders has not been performed. CONCLUSIONS: We show immune-mediated genetic enrichment specifically in FTD, particularly within the HLA region. Our genetic results suggest that for a subset of patients, immune dysfunction may contribute to FTD risk. These findings have potential implications for clinical trials targeting immune dysfunction in patients with FTD.
2018
15
e1002487
0
Broce, Iris; Karch, Celeste M; Wen, Natalie; Fan, Chun C; Wang, Yunpeng; Tan, Chin Hong; Kouri, Naomi; Ross, Owen A; Höglinger, Günter U; Muller, Ulri...espandi
File in questo prodotto:
File Dimensione Formato  
journal.pmed.1002487.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 4.02 MB
Formato Adobe PDF
4.02 MB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1112683
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 101
  • ???jsp.display-item.citation.isi??? 99
social impact